D-0489-2024 Class II Terminated

Recalled by RemedyRepack Inc. — Indiana, PA

FDA drug recall D-0489-2024 was initiated by RemedyRepack Inc. on May 2, 2024 and is designated Class II. Reason for recall: Presence of Foreign Tablets: Manufacturer received a report from a Pharmacist who reported finding a tablet of baclofen in a bottle of 1000-count tramadol The recall status is terminated (terminated Sep 9, 2024). Affected quantity: 23,970 Tablets.

Recall details

Product Type
Drugs
Report Date
May 15, 2024
Initiation Date
May 2, 2024
Termination Date
Sep 9, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
23,970 Tablets

Product description

TraMADol HCl 50 mg Tablet, Packaged as (a) 30-count blister pack, NDC 70518-3824-00; (b) 90-count blister pack, NDC 70518-3824-02; (a) 180-count blister pack, NDC 70518-3824-03; RX ONLY, MFG: Advagen Pharma Limited, Plainsboro. NJ 08536, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 724.465.8762

Reason for recall

Presence of Foreign Tablets: Manufacturer received a report from a Pharmacist who reported finding a tablet of baclofen in a bottle of 1000-count tramadol

Distribution pattern

Nationwide in the USA

Code information

Lots#: (a)J0732085-101023, Exp (b) B2546618-100523, Exp (c) B2546541-100523

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0489-2024
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0489-2024. Report a data issue: hello@regdatalab.com.